« Back
Home /
Cinpanemab Biosimilar（Anti-Alpha-synuclein Reference Antibody）

Cinpanemab Biosimilar（Anti-Alpha-synuclein Reference Antibody）

Item no.	DCC-A664-1mg
Manufacturer	DCChemicals
CASRN	2094516-02-4
Amount	1 mg
Quantity options	100 mg 10 mg 1 mg 5 mg
Category	Neuroscience Molecular Targets for Neuroscience Aging & Neurological Disorders Protein Aggregation, Clearance & Misfolding
Specific against	other
Available
Manufacturer - Applications	Cinpanemab (BIIB054) is a human-derived monoclonal antibody that binds to α-synuclein. Cinpanemab can be used for the research of Parkinson's disease.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Delivery expected until 10/9/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer